Blonanserin Augmentation of Atypical Antipsychotics in Patients with Schizophrenia-Who Benefits from Blonanserin Augmentation?: An Open-Label, Prospective, Multicenter Study

OBJECTIVE: The purpose of this study was to investigate the efficacy and tolerability of atypical antipsychotics (AAPs) with augmentation by blonanserin in schizophrenic patients. METHODS: aA total of 100 patients with schizophrenia who were partially or completely unresponsive to treatment with an...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Psychiatry Investig
Egile Nagusiak: Woo, Young Sup, Park, Joo Eon, Kim, Do-Hoon, Sohn, Inki, Hwang, Tae-Yeon, Park, Young-Min, Jon, Duk-In, Jeong, Jong-Hyun, Bahk, Won-Myong
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Korean Neuropsychiatric Association 2016
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4965658/
https://ncbi.nlm.nih.gov/pubmed/27482249
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4306/pi.2016.13.4.458
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak